The latest news from British Patient Capital
Press release 04 November 2024
British Patient Capital – Full Year Results for the period ending 31 March 2024
Driving long-term growth: British Patient Capital’s total fund and co-investment commitments reach £2.3 billion, retaining its position as the UK’s largest domestic investor in venture and venture growth capital. Total assets under management have now reached £3.125 billion.
Filter Close filters
Displaying 1 - 10 of 72 results
Filter news
Showing 1 - 10 of 72 results
- British Patient Capital announces £5m investment into Cambridge GaN Devices as part of a $32 million Series C funding round
Press release
18 February 2025 - Triple honours for British Patient Capital in King’s New Year honours list 2025
Press release
31 December 2024 -
British Patient Capital announces £8m investment into Tokamak Energy as part of $125m financing roundPress release
20 November 2024 -
British Patient Capital – Full Year Results for the period ending 31 March 2024Press release
04 November 2024 -
British Patient Capital announces £8m investment into Nuclera as part of a $75m Series C financing roundPress release
16 October 2024 -
British Patient Capital announces investment into Purespring Therapeutics as part of £80m Series B financing roundPress release
09 October 2024 -
British Patient Capital makes €25m commitment to Blume Equity Fund I to support companies tackling climate changePress release
17 September 2024 -
British Patient Capital announces total $60m commitment to Atomico’s latest fundsPress release
16 September 2024 -
British Patient Capital Invests £10m in Form3Press release
10 September 2024 - British Patient Capital announces total $90m commitment to Balderton IX and Balderton Growth II
Press release
12 August 2024